The invention discloses a Chinese patent medicine for treating trigeminal neuralgia. The Chinese patent medicine is composed of the following raw materials in parts by weight: 10 to 20 pars of ligusticum wallichii, 10 to 20 parts of wild ginger, 8 to 18 parts of scouring rush, 6 to 17 parts of kaempferia galanga, 5 to 12 parts of centipeda, 5 to 14 parts of xanthium, 5 to 15 parts of dahurian angelica root, 4 to 12 parts of stemona, 4 to 14 parts of inula Britannica, 5 to 12 parts of loquat leaf, 4 to 12 parts of semen oroxyli, 3 to 11 parts of tabasheer, 3 to 10 parts of frankincense, 2 to 11 parts of myrrh, 3 to 12 parts of rhizoma sparganic, 3 to 10 parts of henbit, 3 to 9 parts of helwingia root, 2 to 10 parts of gentiana macrophylla, 2 to 8 parts of fortune loosestrife herb, 2 to 8 parts of pittosporum tobira bark, 2 to 9 parts of turpentine, 3 to 8 parts of sappan wood, 2 to 10 parts of catechu, 1 to 6 parts of myrsinaceae, and 2 to 8 parts of uniflower swisscentaury root. The Chinese patent medicine has the functions of dispelling wind, resolving phlegm, activating blood, freeing collaterals, relieving spasm and pain, and promoting the recovery from trigeminal neuralgia, and has a very good curative effect, which has been proved by the clinical practices.